GLS and neoplasm: Elevated levels of GLS and glutamine transporters enable tumor cells to derive large portions of their energy and macromolecules through glutamine catabolism, leading to glutamine addiction in numerous cancer types including myeloma and glioma (Bolzoni et al., 2016; Márquez et al., 2017).